Hema Dave

6PUBLICATIONS
18CO-AUTHORS
Innate immunityRespiratory diseasesHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 24, 2025
Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphoma.

Keri Toner, Lindsay A Renfro, Hema Dave

|Mar 10, 2023
Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma.

Christopher J Forlenza, Jaclyn Rosenzweig, Audrey Mauguen

|Mar 04, 2022
Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT.

Hannah Kinoshita, Kenneth R Cooke, Melanie Grant

|Sep 08, 2021
Tumor-associated antigen-specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma.

Hema Dave, Madeline Terpilowski, Mimi Mai

|Aug 24, 2019
ROR1 and ROR2-novel targets for neuroblastoma.

Hema Dave, Donna Butcher, Miriam Anver

|Jul 18, 2019
Iatrogenic immunodeficiency-associated lymphoproliferative disorder in a child with B-cell acute lymphoblastic leukemia.

Sanam Shahid, Christopher Rossi, Pranav Vyas

Pageof 1

Frequent Collaborators

2 joint publications

Keri Toner

2 joint publications

Melanie Grant

1 joint publications

Sanam Shahid

1 joint publications

Reuven Schore